Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia

Yildirim, Fatma; Karaman, Irem; Şimşek, Meltem

doi:10.1016/j.medcle.2021.12.011

array:23 ["pii" => "S2387020622003643" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.12.011" "estado" => "S300" "fechaPublicacion" => "2022-08-26" "aid" => "5871" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;159:e25-e26" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S2387020622003655" "issn" => "23870206" "doi" => "10.1016/j.medcle.2022.01.018" "estado" => "S300" "fechaPublicacion" => "2022-08-26" "aid" => "5929" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;159:e27" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Smoking history and clinical outcomes in COVID-19 hospitalized patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "e27" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Antecedentes de tabaquismo y resultados clínicos en pacientes hospitalizados por COVID-19" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marco Rossato, Angelo Di Vincenzo" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Marco" "apellidos" => "Rossato" ] 1 => array:2 [ "nombre" => "Angelo" "apellidos" => "Di Vincenzo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003655?idApp=UINPBA00004N" "url" => "/23870206/0000015900000004/v1_202208270652/S2387020622003655/v1_202208270652/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020622003795" "issn" => "23870206" "doi" => "10.1016/j.medcle.2022.03.011" "estado" => "S300" "fechaPublicacion" => "2022-08-26" "aid" => "5963" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Med Clin. 2022;159:195-204" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Review" "titulo" => "Sarcoidosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "195" "paginaFinal" => "204" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sarcoidosis" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2376 "Ancho" => 3175 "Tamanyo" => 709117 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0065" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Thoracic involvement of sarcoidosis: (A) bilateral hilar lymphadenopathy on chest X-ray; (B) uptake of bilateral hilar lymphadenopathy on positron emission tomography (PET); (C) bilateral involvement of the lung parenchyma (micronodules with predominantly perilymphatic distribution; (D) PET uptake of bilateral lung involvement." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Pilar Brito-Zerón, Roberto Pérez-Álvarez, Manuel Ramos-Casals" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Pilar" "apellidos" => "Brito-Zerón" ] 1 => array:2 [ "nombre" => "Roberto" "apellidos" => "Pérez-Álvarez" ] 2 => array:2 [ "nombre" => "Manuel" "apellidos" => "Ramos-Casals" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775322001786" "doi" => "10.1016/j.medcli.2022.03.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775322001786?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003795?idApp=UINPBA00004N" "url" => "/23870206/0000015900000004/v1_202208270652/S2387020622003795/v1_202208270652/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e25" "paginaFinal" => "e26" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Fatma Yildirim, Irem Karaman, Meltem Şimşek" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Fatma" "apellidos" => "Yildirim" "email" => array:1 [ 0 => "ftagassi@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Irem" "apellidos" => "Karaman" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Meltem" "apellidos" => "Şimşek" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Clinic of Chest Diseases, COVID Intensive Care Unit, Ankara, Turkey" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "School of Medicine, Bahcesehir University, Turkey" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Department of Internal Medicine, COVID Intensive Care Unit, Ankara, Turkey" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efecto de la vitamina C intravenosa en dosis altas sobre el pronóstico en pacientes con neumonía por SARS-CoV-2" ] ] "textoCompleto" => "We read with great interest the study by Kavurgacı et al.,<a class="elsevierStyleCrossRef" href="#bib0030">1</a> which was published online-ahead-of-print in Medicina Clinica. In this retrospective study, 323 patients hospitalized with severe COVID-19 pneumonia were divided into two groups and the clinical features of patients who received high-dose vitamin C (VitC) were compared with those who did not. There was no difference in terms of length of hospital stay, re-admission rate, admission rate to the intensive care unit (ICU), and the need for advanced oxygen therapy between the groups that received and did not receive VitC, whereas the need for advanced medical treatment was higher in the group receiving VitC with no difference in terms of mortality. This is an important issue but there are some practical questions to be answered for a proper clinical extrapolation.Firstly, when the baseline characteristics of the groups that received and did not receive VitC were investigated, there seems no difference in terms of gender and comorbidities. In this study where clinical data was very insufficient, among the inflammatory parameters that was examined in the study, C-reactive protein levels were similar between two groups, whereas ferritin level was higher in the group given VitC (median 415.5 vs 271ng/mL; p=0.029). There was no difference between the groups in terms of SpO2 (87.3±8.7% vs 87.9±8.3%; p=0.07), which was the only clinical data presented in the study. The information obtained from the study regarding the severity of the COVID-19 patients is limited. Considering that this study was retrospective, it is understood that the administration of VitC was done randomly. As emphasized in the introduction part of the study, no scoring was used for cytokine storm in COVID-19 patients. Therefore, VitC delivery criteria should be defined more clearly. In addition, the group which did not receive VitC was older (64.3±14.5 vs 60.2±13.7; p=0.009). The group receiving VitC had an increase in ferritin levels after treatment (415.5 vs 530.6ng/ml; p=0.006). This results are in contrast to the possible expected positive results of VitC in COVID-19.Secondly; the need for advanced medical treatment was higher in the group that received VitC (24.2% vs 8.8%; p<0.001). The studies conducted with the use of VitC in COVID-19 patients with severe pneumonia and hypoxic respiratory failure resulted in positive results with the VitC level varying between 6g/day and 20g/day.<a class="elsevierStyleCrossRef" href="#bib0035">2</a> In the study of Kavurgacı et al., the level of 2g/day given for 3 days seems to be at the supplement level and should be considered as below the treatment dose.COVID-19 can cause acute respiratory distress syndrome (ARDS), secondary infections, and sepsis. An intravenous treatment with high-dose VitC has shown beneficial effects on sepsis and septic shock.<a class="elsevierStyleCrossRef" href="#bib0040">3</a> An intravenous infusion of VitC (50mg/kg body weight) every 6h for 96h significantly decreased mortality and increased the number of ICU-free days in patients with sepsis and ARDS, compared to the control group.<a class="elsevierStyleCrossRef" href="#bib0045">4</a> Although it was stated that all of the patients in Kavurgacı’s et al.<a class="elsevierStyleCrossRef" href="#bib0030">1</a>’s study had severe acute respiratory syndrome, there was no data regarding the PaO2/FIO2 ratios of the patients, and the type of oxygen respiratory support treatments applied. It was reported that mortality rates were similar between groups that received and did not receive VitC (11.1% vs 14.1%; p=0.52). However, in this study, no data regarding the APACHE-II (Acute Physiology and Chronic Health Evaluation) and SOFA (Sequential Organ Failure Assessment Score) scores of the patients were presented. In addition, in Kavurgacı’s et al. study only 7% of the patients were followed up in the ICU which may have affected the mortality assessment. In our recent study, we included the patients who were intubated in the ICU with the diagnosis of COVID-19 associated ARDS and who have ICU follow-up for at least 48h. We accepted as high-dose VitC being equal to or above 200/mg/kg/day for at least 4 days. It was observed that high-dose VitC reduced mortality and prolonged life expectancy in this severe patient group. In the daily SOFA follow-up, daily improvement in the score was detected in our VitC group.<a class="elsevierStyleCrossRef" href="#bib0050">5</a>Further prospective clinical trials need to confirm appropriate usage of VitC in COVID-19 patients with severe acute respiratory syndrome.Conflict of interestThe authors declared no conflict of interest." "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia [published online ahead of print, 2021 May 11]" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "K. Suna" 1 => "U.Ş. Melahat" 2 => "Y. Murat" 3 => "Ö.E. Figen" 4 => "Ö. Ayperi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.medcli.2021.04.010" "Revista" => array:2 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2021" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Zhao" 1 => "Y. Ling" 2 => "J. Li" 3 => "Y. Peng" 4 => "J. Huang" 5 => "Y. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.21037/apm-20-1387" "Revista" => array:6 [ "tituloSerie" => "Ann Palliat Med" "fecha" => "2021" "volumen" => "10" "paginaInicial" => "1599" "paginaFinal" => "1609" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33222462" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P.E. Marik" 1 => "V. Khangoora" 2 => "R. Rivera" 3 => "M.H. Hooper" 4 => "J. Catravas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.chest.2016.11.036" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2017" "volumen" => "151" "paginaInicial" => "1229" "paginaFinal" => "1238" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27940189" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.D. Truwit" 1 => "R.D. Hite" 2 => "P.E. Morris" 3 => "C. DeWilde" 4 => "A. Priday" 5 => "B. Fisher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2019.11825" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2019" "volumen" => "322" "paginaInicial" => "1261" "paginaFinal" => "1270" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31573637" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of high dose vitamin c on patient outcomes in ARDS patients admitted to intensive care with COVID-19; multi-center retrospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.C. Yüksel" 1 => "F. Yildirim" 2 => "C. Kıraklı" 3 => "S. Temel" 4 => "S. Güzeldağ" 5 => "Z. Gullu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s40635-021-00413-8" "Revista" => array:6 [ "tituloSerie" => "ICMx" "fecha" => "2021" "volumen" => "9" "numero" => "Suppl. 1" "paginaInicial" => "51" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34633565" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015900000004/v1_202208270652/S2387020622003643/v1_202208270652/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015900000004/v1_202208270652/S2387020622003643/v1_202208270652/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003643?idApp=UINPBA00004N"]

ISSN: 2387-0206

Launched in 1943, Medicina Clínica is a fortnightly journal aimed at the promotion of clinical research and practice among internal medicine and other specialists. The key characteristics of Medicina Clínica are the scientific and methodological rigor of its manuscripts, the topicality of its contents, and, especially, its practical focus with highly useful information for clinical practice. Medicina Clínica is predominantly interested in publishing original research manuscripts, which are rigorously selected according to their quality, originality, and interest, and also in continued medical education-oriented manuscripts, which are commissioned by the journal to relevant authors (Editorials, Reviews, and Diagnosis and Treatment). These manuscripts contain updated topics with a major clinical or conceptual relevance in modern medicine. The journal adheres to the standards of academic research publications in all aspects including peer-review and ethical principles. Medicina Clínica is included in the General and Internal Medicine category of Thomson Reuters.

See more Open Access Option

Indexed in:

Current Contents/Clinical Medicine, Journal Citation Reports, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, MEDES, PASCAL, SCOPUS, SciVerse ScienceDirect

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.371

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.511

View more metrics

Journal Information

Previous article | Next article

Vol. 159. Issue 4.

Pages e25-e26 (August 2022)

Export reference

Download PDF

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)

Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”

Subscribe to

Medicina Clínica (English Edition)

More information

Purchase

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now

Contact

Phone for subscriptions and reporting of errors

From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.

Calls from Spain

932 415 960

Calls from outside Spain

+34 932 415 960

E-mail

atencionalcliente@elsevier.com

Publish in

Medicina Clínica

Tools

Indexed in:

Follow us:

Subscribe:

Article

Subscribe to our newsletter